Within- and between-subject biological variation estimates for the enumeration of lymphocyte deep immunophenotyping and monocyte subsets

Kai Guo,Xiaoran Feng,Lei Xu,Chenbin Li,Yating Ma,Mingting Peng

DOI: https://doi.org/10.1515/cclm-2024-0371

2024-06-01

Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract:This study aimed to deliver biological variation (BV) estimates for 25 types of lymphocyte subpopulations subjected to deep immunophenotyping (memory T/B cells, regulatory T cells, etc.) and classical, intermediate, and nonclassical monocyte subsets based on the full spectrum flow cytometry (FS-FCM) and a Biological Variation Data Critical Appraisal Checklist (BIVAC) design. Samples were collected biweekly from 60 healthy Chinese adults over 10 consecutive two-week periods. Each sample was measured in duplicate within a single run for lymphocyte deep immunophenotyping and monocyte subset determination using FS-FCM, including the percentage (%) and absolute count (cells/μL). After trend adjustment, a Bayesian model was applied to deliver the within-subject BV (CV I ) and between-subject BV (CV G ) estimates with 95 % credibility intervals. Enumeration (% and cells/μL) for 25 types of lymphocyte deep immunophenotyping and three types of monocyte subset percentages showed considerable variability in terms of CV I and CV G . CV I ranged from 4.23 to 47.47 %. Additionally, CV G ranged between 10.32 and 101.30 %, except for CD4 + effector memory T cells re-expressing CD45RA. No significant differences were found between males and females for CV I and CV G estimates. Nevertheless, the CV G s of PD-1 + T cells (%) may be higher in females than males. Based on the desired analytical performance specification, the maximum allowable imprecision immune parameter was the CD8 + PD-1 + T cell (cells/μL), with 23.7 %. This is the first study delivering BV estimates for 25 types of lymphocyte subpopulations subjected to deep immunophenotyping, along with classical, intermediate, and nonclassical monocyte subsets, using FS-FCM and adhering to the BIVAC design.

medical laboratory technology